By
Trending Posts
Cervical Cancer Detection AI: How Is BD Applying…
BD and Techcyte Partner on AI-Based Application to Modernize Cervical Cancer Screening FRANKLIN LAKES, N.J. & OREM, Utah…
Merck and Variational AI Collaborate to Advance AI-Driven…
Vancouver, BC – January 25, 2024 Variational AI, a leader in generative AI drug discovery, has announced a…
AI Meets Neuroscience: BullFrog AI and LIBD Unlock…
Gaithersburg, Md – Jan 17 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company…
Nvidia Expands AI Drug Discovery with Amgen and…
JPM Conference, January 8, 2024 Nvidia is advancing its footprint in AI-powered drug discovery through new collaborations with…
Insilico Medicine Achieves Milestone with Positive Phase I…
CAMBRIDGE, Massachusetts, January 7, 2024 Insilico Medicine, a clinical-stage leader in generative AI-driven drug discovery and development, has…
Bristol Myers Squibb Taps AI-Driven Discovery with Terray…
Los Angeles – Dec 14, 2023 Terray Therapeutics, a leader in AI-driven small molecule discovery, has entered into…
PostEra and Amgen Forge AI Drug Discovery Partnership…
Boston – Nov 16, 2023 Advancing Small Molecule Therapeutics with AI PostEra has entered into a multi-target research…
NVIDIA Backs Terray Therapeutics to Advance Generative AI…
Los Angeles – Nov 9, 2023 Terray Therapeutics, a biotechnology company pioneering AI-driven small molecule discovery, has secured…
Merck (HQ Germany) Strengthens AI-Driven Drug Discovery with…
Darmstadt, Germany – Sept 20, 2023 Advancing AI-Powered Drug Development in Oncology, Neurology, and Immunology Merck, a global…
Trending Posts
Latest Stories
How Will METiS Technologies’ RMB 400 Million Series D Raise Accelerate Beijing’s AI-Powered Nanodelivery Revolution in Biopharma by 2027?
Key Highlights Strong Capital Infusion to Accelerate AI-Driven Nanotechnology DevelopmentThe recent RMB 400 million (~$57…
How Will Lantern Pharma’s PredictBBB.ai Advance with 94% Accuracy Revolutionize CNS Drug Development?
Key Highlights Breakthrough AI Methodology Sets New Industry BenchmarkLantern’s proprietary ensemble of machine learning algorithms—including…
Can Phare Bio’s AI-Driven Antibiotic Discovery Win Herald a New Era in Combating Antimicrobial Resistance?
Key Highlights Harnessing Generative AI to Revolutionize Antibiotic DiscoveryPhare Bio leverages cutting-edge AI to drastically…
Will AbbVie’s $1 Billion Move to Acquire Gilgamesh Pioneer a New Era in Mental Health Drug Development?
Key Highlights Advanced Acquisition Talks Reflect Growth Strategy Amid Sector InterestAbbVie, following over $20 billion…
Gallery
